A Phase I Study to Evaluate XTR003 in Healthy Chinese Volunteers

NCT05136391 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease (CAD)

Interventions

DRUG: XTR003

Sponsor

Sinotau Pharmaceutical Group